"Cross-Linking Reagents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Reagents with two reactive groups, usually at opposite ends of the molecule, that are capable of reacting with and thereby forming bridges between side chains of amino acids in proteins; the locations of naturally reactive areas within proteins can thereby be identified; may also be used for other macromolecules, like glycoproteins, nucleic acids, or other.
| Descriptor ID |
D003432
|
| MeSH Number(s) |
D27.720.470.410.210
|
| Concept/Terms |
Cross-Linking Reagents- Cross-Linking Reagents
- Reagents, Cross-Linking
- Crosslinking Reagents
- Reagents, Crosslinking
- Bifunctional Reagents
- Reagents, Bifunctional
- Cross Linking Reagents
- Linking Reagents, Cross
- Reagents, Cross Linking
|
Below are MeSH descriptors whose meaning is more general than "Cross-Linking Reagents".
Below are MeSH descriptors whose meaning is more specific than "Cross-Linking Reagents".
This graph shows the total number of publications written about "Cross-Linking Reagents" by people in this website by year, and whether "Cross-Linking Reagents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 0 | 1 | 1 |
| 2001 | 0 | 1 | 1 |
| 2002 | 0 | 2 | 2 |
| 2003 | 0 | 5 | 5 |
| 2005 | 0 | 4 | 4 |
| 2006 | 1 | 1 | 2 |
| 2007 | 0 | 2 | 2 |
| 2008 | 1 | 1 | 2 |
| 2009 | 1 | 0 | 1 |
| 2010 | 1 | 1 | 2 |
| 2011 | 1 | 6 | 7 |
| 2012 | 2 | 0 | 2 |
| 2013 | 0 | 1 | 1 |
| 2014 | 1 | 1 | 2 |
| 2015 | 0 | 1 | 1 |
| 2016 | 0 | 1 | 1 |
| 2018 | 1 | 2 | 3 |
| 2019 | 0 | 1 | 1 |
| 2021 | 1 | 1 | 2 |
| 2024 | 4 | 0 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cross-Linking Reagents" by people in Profiles.
-
McCahill AL, Zhang T, Saven JG, Kloxin CJ, Pochan DJ. Peptide Bundlemer Networks or Lattices: Controlling Cross-Linking and Self-Assembly Using Protein-like Display of Chemistry. ACS Nano. 2024 09 17; 18(37):25695-25707.
-
Syed ZA, Yu J, Crespo MA, Daher ND, Chang CY. Dynamics of Corneal Swelling With Hypoosmolar Riboflavin After Induction During Corneal Collagen Crosslinking in Patients With Progressive Keratoconus. Cornea. 2024 Jun 28; 44(5):567-574.
-
Cehelyk EK, Syed ZA. Long-term outcomes of corneal crosslinking. Curr Opin Ophthalmol. 2024 Jul 01; 35(4):315-321.
-
Syed ZA, Tomaiuolo M, Zhang Q, Prajna V, Hyman L, Rapuano CJ. Trends and Sociodemographic Patterns in Keratoconus Management 2015-2020: An American Academy of Ophthalmology IRIS? Registry Analysis. Ophthalmology. 2024 08; 131(8):892-901.
-
Cinar Y, Han CC, Sahin A, Syed ZA. Long term results of accelerated corneal collagen cross-linking in pediatric keratoconus. Eur J Ophthalmol. 2021 Nov; 31(6):3494-3499.
-
Chandramouly G, Liao S, Rusanov T, Borisonnik N, Calbert ML, Kent T, Sullivan-Reed K, Vekariya U, Kashkina E, Skorski T, Yan H, Pomerantz RT. Pol? promotes the repair of 5'-DNA-protein crosslinks by microhomology-mediated end-joining. Cell Rep. 2021 03 09; 34(10):108820.
-
Park J, Fertala A, Tomlinson RE. Naproxen impairs load-induced bone formation, reduces bone toughness, and diminishes woven bone formation following stress fracture in mice. Bone. 2019 07; 124:22-32.
-
Ovadia EM, Colby DW, Kloxin AM. Designing well-defined photopolymerized synthetic matrices for three-dimensional culture and differentiation of induced pluripotent stem cells. Biomater Sci. 2018 May 29; 6(6):1358-1370.
-
Khoynezhad A, DelaRosa J, Moon MR, Brinkman WT, Thompson RB, Desai ND, Malaisrie SC, Girardi LN, Bavaria JE, Reece TB. Facilitating Hemostasis After Proximal Aortic Surgery: Results of The PROTECT Trial. Ann Thorac Surg. 2018 05; 105(5):1357-1364.
-
Rapuano PB, Scanameo AH, Amponin DE, Paulose SA, Zyablitskaya M, Takaoka A, Suh LH, Nagasaki T, Trokel SL, Paik DC. Antimicrobial Studies Using the Therapeutic Tissue Cross-Linking Agent, Sodium Hydroxymethylglycinate: Implication for Treating Infectious Keratitis. Invest Ophthalmol Vis Sci. 2018 01 01; 59(1):332-337.